Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-27

Clinical Trial Update: A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia. [NA]

View source ↗

Summary

A terminated clinical trial evaluating Medical Cannabis Oil for agitation and disruptive behaviors in dementia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medical Cannabis Oil (cannabis oil)

Snippet

Sponsor: M. H MediCane Ltd. | Conditions: Agitation,Psychomotor, Disruptive Behavior | NA | Status: TERMINATED